$4.08
0.43[11.78%]
Last update: 9:20AM Get Real Time Here
GT Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of GT Biopharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/13/2024 | AM | GTBP | Q1 | -$0.30 | -$2.70 | — | — | $0.00 | — | — | — | Get Alert |
03/26/2024 | PM | GTBP | Q4 | -$5.40 | -$2.70 | -$2.14 | 20.74% | $0.00 | — | $0.00 | — | Get Alert |
11/01/2023 | AM | GTBP | Q3 | -$6.60 | -$3.00 | -$1.80 | 40.00% | $0.00 | — | $0.00 | — | Get Alert |
08/07/2023 | AM | GTBP | Q2 | -$3.00 | -$3.00 | -$1.50 | 50.00% | $0.00 | — | $0.00 | — | Get Alert |
05/15/2023 | AM | GTBP | Q1 | -$5.10 | -$4.20 | -$0.30 | 92.86% | $0.00 | — | $0.00 | — | Get Alert |
03/30/2023 | PM | GTBP | Q4 | -$15.60 | -$5.10 | -$5.40 | -5.88% | $0.00 | — | $0.00 | — | Get Alert |
10/31/2022 | PM | GTBP | Q3 | -$5.10 | -$3.30 | -$6.60 | -100.00% | $0.00 | — | $0.00 | — | Get Alert |
08/11/2022 | AM | GTBP | Q2 | -$4.50 | -$0.17 | -$3.00 | -1664.71% | $0.00 | — | $0.00 | — | Get Alert |
05/16/2022 | AM | GTBP | Q1 | -$54.90 | -$9.30 | -$5.10 | 45.16% | $0.00 | — | $0.00 | — | Get Alert |
03/28/2022 | PM | GTBP | Q4 | -$102.00 | -$6.30 | -$15.60 | -147.62% | $0.00 | — | $0.00 | — | Get Alert |
11/10/2021 | PM | GTBP | Q3 | -$19.20 | -$6.30 | -$5.10 | 19.05% | $0.00 | — | $0.00 | — | Get Alert |
08/23/2021 | PM | GTBP | Q2 | — | -$8.40 | -$4.50 | 46.43% | — | — | $0.00 | — | Get Alert |
05/17/2021 | PM | GTBP | Q1 | — | — | -$54.90 | — | — | — | $0.00 | — | Get Alert |
04/19/2021 | AM | GTBP | Q4 | — | -$7.20 | -$102.00 | -1316.67% | — | — | $0.00 | — | Get Alert |
GT Biopharma (GTBP) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on March 26, 2024 for Q4.
The Actual EPS was $-2.14, which beat the estimate of $-2.70.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.